We explain, via videos of true stories, the social impact of our business, our milestones and updates, and the latest news from the sectors where we operate.
Since its foundation in 1975, Bioiberica has been focused on the production of heparin. The company understood that it was an active ingredient indispensable for human health and that it was important to be able to offer the maximum guarantees of safety and traceability. Today, one out of every five heparin doses administered worldwide has been developed and manufactured by Bioibérica.
Although they may appear immune to thrombosis due to their physical training, athletes are not risk free. In this story we’ll meet Jennifer Pareja, world water polo champion, and how heparin helped her to continue his sports career.
Who discovered Heparin? Was it Jay McLean, the student? Or was it its teacher, William Howell? What is clear is that, 100 years ago, that scientific discovery Made his mark on the history of medicine forever.
Aquaculture now produces more than half of the seafood consumed worldwide and Spain has become the European Union's main producer. Today we wanted to get to know this sector more in depth and analyse how Bioibérica's Animal Nutrition division contributes to it.
The Catalan Institute of Bioengineering, the Barcelona Institute of Global Health and Bioibérica have joined forces to study the development of new compounds derived from heparin to fight malaria, a disease that infects 200 million people each year and causes half a million deaths.
